Efficacy and Tolerability of Fluvastatin and Simvastatin in Hypercholesterolaemic Patients

被引:0
|
作者
J. A. Tobert
A. V. Katdare
K.-L. Schulte
S. Beil
机构
[1] Merck Research Laboratories,Departments of Clinical Research and Pharmaceutical Research and Development
[2] Merck Research Laboratories,Departments of Clinical Research and Pharmaceutical Research and Development
[3] Ev. Krankenhaus Königin Elizabeth Herzberge,undefined
[4] Städt. Krankenhause,undefined
关键词
D O I
10.2165/00044011-199713010-00007
中图分类号
学科分类号
摘要
引用
收藏
页码:56 / 57
页数:1
相关论文
共 50 条
  • [1] Efficacy and tolerability of fluvastatin and simvastatin in hypercholesterolaemic patients. Reply
    Schulte, KL
    Beil, S
    CLINICAL DRUG INVESTIGATION, 1997, 13 (01) : 56 - 57
  • [2] Efficacy and tolerability of fluvastatin and simvastatin in hypercholesterolaemic patients - A double-blind, randomised, parallel-group comparison
    Schulte, KL
    Beil, S
    CLINICAL DRUG INVESTIGATION, 1996, 12 (03) : 119 - 126
  • [3] Comparison of the efficacy, safety and tolerability of policosanol versus fluvastatin in elderly hypercholesterolaemic women
    Fernández, JC
    Más, R
    Cataño, G
    Menéndez, R
    Amor, AM
    González, RM
    Alvarez, E
    CLINICAL DRUG INVESTIGATION, 2001, 21 (02) : 103 - 113
  • [4] Comparison of the Efficacy, Safety and Tolerability of Policosanol versus Fluvastatin in Elderly Hypercholesterolaemic Women
    J. C. Fernández
    R. Más
    G. Castaño
    R. Menéndez
    A. M. Amor
    R. M. González
    E. Alvarez
    Clinical Drug Investigation, 2001, 21 : 103 - 113
  • [5] DOUBLE-BLIND COMPARISON OF THE EFFICACY AND TOLERABILITY OF SIMVASTATIN AND FLUVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
    OSE, L
    SCOTT, R
    BRUSCO, O
    UGARTE, AC
    DESCAMPS, O
    HELLER, F
    PAQUOT, N
    SCHEEN, A
    BERTOLAMI, MC
    FORTI, N
    RICHTER, W
    SELMAIER, A
    ZIEGLASCH, HJ
    KLOER, H
    BADE, R
    WANNER, C
    KOESTER, W
    KRAEMERGUTH, A
    BILIANOU, H
    LEFKOS, N
    EFTHIMIADIS, A
    KASTELEIN, J
    VANDAM, M
    VANDEWIEL, A
    LINTOTT, C
    SUNDT, E
    ISTAD, H
    LOENNECHEN, CW
    UTNE, E
    HOLE, T
    SKARE, S
    URHEIM, S
    CAMPODINCO, S
    MORALES, R
    IZA, A
    ALVAREZ, L
    SY, R
    YEBES, R
    LEE, CY
    TAN, A
    QUEK, S
    VERMAK, WJH
    VORSTER, HH
    RAAL, FJ
    KELLER, U
    NOSEDA, G
    BONETTI, T
    CRAWFORD, GM
    BLOOMFIELD, P
    SUTHERLAND, K
    CLINICAL DRUG INVESTIGATION, 1995, 10 (03) : 127 - 138
  • [7] The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients - A comparison of atorvastatin, simvastatin, lovastatin and fluvastatin
    Koren, MJ
    Smith, DG
    Hunninghake, DB
    Davidson, MH
    McKenney, JM
    Weiss, SR
    Schrott, HG
    Henley, RW
    Tresh, P
    McLain, RW
    Bakker-Arkema, RG
    Black, DM
    PHARMACOECONOMICS, 1998, 14 (01) : 59 - 70
  • [8] FLUVASTATIN EFFICACY AND TOLERABILITY IN COMPARISON AND IN COMBINATION WITH CHOLESTYRAMINE
    HAGEN, E
    ISTAD, H
    OSE, L
    BODD, E
    ERIKSEN, HM
    SELVIG, V
    BARD, JM
    FRUCHART, JC
    BORGE, M
    WOLF, MC
    PFISTER, P
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 46 (05) : 445 - 449
  • [9] Efficacy of atorvastatin in patients with severe familiar hypercholesterolemia treated with pravastatin, fluvastatin and simvastatin
    Fornengo, P
    D'Affuso, S
    Bruno, A
    Pagano, G
    ATHEROSCLEROSIS, 1999, 144 : 190 - 190
  • [10] EFFICACY AND TOLERABILITY OF GEMFIBROZIL IN HYPERCHOLESTEROLEMIC PATIENTS PREVIOUSLY TREATED WITH SIMVASTATIN
    VERGANI, C
    STEFANONI, P
    ADVANCES IN THERAPY, 1993, 10 (04) : 189 - 196